Can Alpha Cognition’s new manufacturing process strengthen ZUNVEYL market protection?
Alpha Cognition publishes a ZUNVEYL manufacturing patent application as sales grow, targeting process protection through 2045.
Pharma & Biotech
Pharma & Biotech
Could Absci’s ABS-201 open a new biologic pathway for androgenetic alopecia treatment?
Absci’s interim ABS-201 data strengthen the early case for a long-acting PRLR antibody in androgenetic alopecia and AI-designed biologics.